Filter by: Subject

Filter by: Subject

Results Per Page:

Tuberculosis (TB) (18)
Mycobacterium tuberculosis (MTB) (6)
SDG-03: Good health and well-being (4)
Multidrug-resistant (MDR) (3)
South Africa (SA) (3)
Whole genome sequencing (WGS) (3)
Bedaquiline (2)
Diagnosis (2)
Drug resistance (2)
Drug susceptibility testing (DST) (2)
Drug-resistant tuberculosis (2)
Ethiopia (2)
Human immunodeficiency virus (HIV) (2)
Meta-analysis (2)
Tuberculosis transmission (2)
18F-FDG PET/CT (1)
Acquired immune deficiency syndrome (AIDS) (1)
Anti-tuberculous treatment (ATT) (1)
Antiretroviral therapy (ART) (1)
Bedaquiline-pretonamid-linezolid (BPaL) (1)
Beta-lactams (1)
Bias analysis (1)
Biofilm formation (1)
Broth micro-dilution assay (BMD) (1)
Cigarette smoke (1)
Cigarette smoke condensate (CSC) (1)
Diagnostic techniques and procedures (1)
Diagnostice escape (1)
Drug sensitivity testing (1)
Drug-resistant tuberculosis (DRTB) (1)
Drug-sensitive pulmonary tuberculosis (DS-PTB) (1)
End-of-treatment (EOT) (1)
Epidemiological cut-off value 99% (ECV99) (1)
Extensively drug-resistant (XDR) (1)
External quality assessment (EQA) (1)
Gene mutation (1)
Genotypes (1)
Genotypically wild type (gWT) (1)
Growth (1)
HIV-TB coinfection (1)
Hollow fiber model system (1)
Infection (1)
Laboratory techniques and procedures (1)
Latent TB infection (LTBI) (1)
Lineages (1)
Lipoarabinomannan (1)
Lipoarabinomannan (LAM) (1)
Low- and middle-income countries (LMICs) (1)
MDR outbreak strains (1)
MDR tuberculosis (MDR-TB) (1)
MDR-TB (1)
Metabolism (1)
Minimum inhibitory concentration (MIC) (1)
Missing data (1)
Molecular drug susceptibility testing (mDST) (1)
Molecular medicine (1)
MPT64 (1)
Multidrug resistant (MDR) (1)
Multidrug-resistant tuberculosis (1)
Multidrug-resistant tuberculosis (MDR-TB) (1)
Mycobacterial antigens (1)
Network modeling (1)
Network models (1)
Pharmacodynamics (1)
Pharmacokinetics (1)
Pleural fluid mononuclear cells (1)
Pleural fluid mononuclear cells (PFMC) (1)
Pleural tuberculosis (1)
Point-of-care (POC) (1)
Point-of-care systems (1)
Pulmonary tuberculosis (1)
Relapse (1)
Residual metabolic activity (RMA) (1)
Resistance evolution (1)
Resistance-associated variant (RAV) (1)
Retention in care (1)
Rifampicin-resistant tuberculosis (1)
Risk factor (1)
Routine data (1)
Spine (1)